Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020.

Democratic Republic of the Congo Ebola Ebolavirus capture-recapture contact tracing disease outbreaks viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 1 12 2021
Statut: ppublish

Résumé

Despite its critical role in containing outbreaks, the efficacy of contact tracing, measured as the sensitivity of case detection, remains an elusive metric. We estimated the sensitivity of contact tracing by applying unilist capture-recapture methods on data from the 2018-2020 outbreak of Ebola virus disease in the Democratic Republic of the Congo. To compute sensitivity, we applied different distributional assumptions to the zero-truncated count data to estimate the number of unobserved case-patients with any contacts and infected contacts. Geometric distributions were the best-fitting models. Our results indicate that contact tracing efforts identified almost all (n = 792, 99%) of case-patients with any contacts but only half (n = 207, 48%) of case-patients with infected contacts, suggesting that contact tracing efforts performed well at identifying contacts during the listing stage but performed poorly during the contact follow-up stage. We discuss extensions to our work and potential applications for the ongoing coronavirus pandemic.

Identifiants

pubmed: 34808076
doi: 10.3201/eid2712.204958
pmc: PMC8632194
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3063-3072

Références

N Engl J Med. 2019 Jul 25;381(4):373-383
pubmed: 31141654
Emerg Infect Dis. 2015 Dec;21(12):2265-7
pubmed: 26583831
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
Nature. 2005 Nov 17;438(7066):355-9
pubmed: 16292310
One Health. 2019 Dec 05;9:100117
pubmed: 31993475
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):338-42
pubmed: 8990210
Am J Epidemiol. 2011 Dec 1;174(11):1246-55
pubmed: 22071585
Front Public Health. 2016 Jun 22;4:130
pubmed: 27446896
Lancet Infect Dis. 2015 May;15(5):507-8
pubmed: 25932579
PLoS Negl Trop Dis. 2018 Sep 12;12(9):e0006762
pubmed: 30208032
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005747
pubmed: 28991915
Lancet. 2018 Jul 21;392(10143):213-221
pubmed: 30047375
PLoS One. 2014 Aug 15;9(8):e104786
pubmed: 25127257
Philos Trans R Soc Lond B Biol Sci. 2019 Jul 8;374(1776):20180276
pubmed: 31104603
Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721):
pubmed: 28396471
J Epidemiol Community Health. 2020 Oct;74(10):861-866
pubmed: 32576605
BMC Health Serv Res. 2019 Dec 16;19(1):967
pubmed: 31842870
Clin Infect Dis. 2020 Nov 5;71(8):1960-1961
pubmed: 32526016
BMC Infect Dis. 2018 Apr 11;18(1):172
pubmed: 29642869
Asian Pac J Trop Med. 2016 Sep;9(9):851-855
pubmed: 27633297
Prev Vet Med. 2015 Jul 1;120(3-4):253-64
pubmed: 25962955
Int J Infect Dis. 2020 Aug;97:197-201
pubmed: 32534143
PLoS Med. 2021 Apr 1;18(4):e1003587
pubmed: 33793554
Euro Surveill. 2020 Jan;25(2):
pubmed: 31964460
N Engl J Med. 2014 Oct 16;371(16):1481-95
pubmed: 25244186
PLoS One. 2019 Sep 26;14(9):e0223104
pubmed: 31557243
Am J Trop Med Hyg. 2014 May;90(5):790-793
pubmed: 24515940
Biometrics. 2021 Mar;77(1):237-248
pubmed: 32282946
MMWR Morb Mortal Wkly Rep. 2020 Jan 10;69(1):14-19
pubmed: 31917783

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH